SRZN - Why Is Regenerative Medicine-Focused Surrozen Stock Trading Lower On Monday? | Benzinga
Monday, Surrozen Inc (NASDAQ:SRZN) entered into a private placement to purchase shares of common stock, pre-funded warrants, and accompanying warrants.
If the warrants to purchase common stock are exercised in full, the private placement would provide approximately $192.5 million in gross proceeds and result in the issuance of approximately 12.2 million shares of common stock.
At the closing, the company will issue 1.09 million shares and pre-funded warrants to purchase 40,000 shares at $15.50 and $15.4999, respectively, for aggregate gross proceeds ...